Onlymyhealth8h
Diabetes: How It Harms Your Heart, Kidneys, Eyes, And More Over Time
Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...
Diabetes medication may be effective in helping people drink less alcohol, research finds
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
Verywell Health on MSN19h
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
FDA approves Azurity Pharmaceuticals’ Danziten for CML treatment
The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...
News Medical on MSN14h
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
News Medical on MSN15h
New drug strategy reverses resistance to immunotherapy in pancreatic cancer
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.
The American Journal of Managed Care18h
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...